Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson’s Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine
Sponsor: ACADIA Pharmaceuticals Inc. Information provided by (Responsible Party): ACADIA Pharmaceuticals Inc. Brief Summary: This is a pilot, hypothesis-generating study…
